These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 781132)

  • 1. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs.
    Sohnle PG; Frank MM; Kirkpatrick CH
    J Immunol; 1976 Aug; 117(2):523-30. PubMed ID: 781132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of neutrophils and delayed hypersensitivity in the clearance of experimental cutaneous candidiasis in mice.
    Wilson BD; Sohnle PG
    Am J Pathol; 1986 May; 123(2):241-9. PubMed ID: 3518475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of possible mechanisms of basophil accumulation in experimental cutaneous candidiasis in guinea pigs.
    Sohnle PG; Kirkpatrick CH
    J Allergy Clin Immunol; 1977 Feb; 59(2):171-7. PubMed ID: 833382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice.
    Sohnle PG; Hahn BL
    J Lab Clin Med; 1993 Feb; 121(2):235-43. PubMed ID: 8433039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of experimental cutaneous candidiasis in guinea pigs under the suppressed polymorphonuclear leukocyte chemotaxis by colchicine.
    Miyachi Y; Horio T; Imamura S
    Arch Dermatol Res; 1981; 271(4):373-80. PubMed ID: 7332347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor.
    Djeu JY; Blanchard DK
    J Immunol; 1987 Oct; 139(8):2761-7. PubMed ID: 2443572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.
    Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB
    Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte stimulation in Candida albicans infections.
    Frisk A; von Stedingk LV; Wasserman J
    Sabouraudia; 1974 Mar; 12(1):87-94. PubMed ID: 4210102
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The adjuvant and specific activity of transfer factors to Candida albicans antigens].
    Borysov VA; Cheusova ZV; Molozhava OS
    Fiziol Zh (1994); 1998; 44(4):3-9. PubMed ID: 9669168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation in response to Candida.
    Domer JE; Garner RE
    Immunol Ser; 1989; 47():293-317. PubMed ID: 2490080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular immunity in patients sensitized to Candida albicans and its corresponding humoral response.
    Oehling A; Crisci CD; Subirá ML; Jerez J
    Allergol Immunopathol (Madr); 1976; 4(5):333-44. PubMed ID: 795291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor.
    Djeu JY; Blanchard DK; Halkias D; Friedman H
    J Immunol; 1986 Nov; 137(9):2980-4. PubMed ID: 3093587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact sensitivity to Candida albicans--comparative studies in man and animal (guinea-pig).
    Tagami H; Urano-Suehisa S; Hatchome N
    Br J Dermatol; 1985 Oct; 113(4):415-24. PubMed ID: 3904808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor T cells role in the unresponsiveness to Candida albicans in chronic mucocutaneous candidiasis.
    Barnaba V; Zaccari C; Levrero M; Balsano F
    Boll Ist Sieroter Milan; 1985; 64(2):126-30. PubMed ID: 3161525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of delayed-type hypersensitivity and interferon-gamma to Candida albicans and anti-hen-egg white lysozyme antibody as phenotypic markers of enhanced bovine immune response.
    Heriazon A; Yager JA; Sears W; Mallard BA
    Vet Immunol Immunopathol; 2009 May; 129(1-2):93-100. PubMed ID: 19155071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro immunity of rat peritoneal macrophages to Candida albicans.
    Joshi KR; Joshi H
    Indian J Chest Dis Allied Sci; 2000; 42(4):341-4. PubMed ID: 15597683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration inhibition experiments with mixtures of human peripheral blood lymphocytes and guinea pig peritoneal exudate cells.
    Marsman AJ; van der Hart M; Walig C; Eijsvoogel VP
    Eur J Immunol; 1972 Dec; 2(6):546-50. PubMed ID: 4569997
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and immunological study of 2 cases of systemic candidiasis].
    Prandi G; Lasagni A; Stefani B
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):65-72. PubMed ID: 66059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of complement in the lesions of experimental cutaneous candidiasis in guinea pigs.
    Sohnle PG; Kirkpatrick CH
    J Cutan Pathol; 1976; 3(5):232-8. PubMed ID: 1018063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.